1 Study Coverage
1.1 Durvalumab Product Introduction
1.2 Global Durvalumab Outlook 2017 VS 2022 VS 2028
1.2.1 Global Durvalumab Sales in US$ Million for the Year 2017-2028
1.2.2 Global Durvalumab Sales in Volume for the Year 2017-2028
1.3 United States Durvalumab Outlook 2017 VS 2022 VS 2028
1.3.1 United States Durvalumab Sales in US$ Million for the Year 2017-2028
1.3.2 United States Durvalumab Sales in Volume for the Year 2017-2028
1.4 Durvalumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Durvalumab in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Durvalumab Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Durvalumab Market Dynamics
1.5.1 Durvalumab Industry Trends
1.5.2 Durvalumab Market Drivers
1.5.3 Durvalumab Market Challenges
1.5.4 Durvalumab Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Durvalumab Market Segment by Type
2.1.1 2.4mL Injection
2.1.2 10mL Injection
2.2 Global Durvalumab Market Size by Type
2.2.1 Global Durvalumab Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Durvalumab Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Durvalumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Durvalumab Market Size by Type
2.3.1 United States Durvalumab Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Durvalumab Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Durvalumab Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Durvalumab Market Segment by Application
3.1.1 Locally Advanced Urothelial Carcinoma
3.1.2 Metastatic Urothelial Carcinoma
3.1.3 Other
3.2 Global Durvalumab Market Size by Application
3.2.1 Global Durvalumab Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Durvalumab Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Durvalumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Durvalumab Market Size by Application
3.3.1 United States Durvalumab Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Durvalumab Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Durvalumab Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Durvalumab Competitor Landscape by Company
4.1 Global Durvalumab Market Size by Company
4.1.1 Top Global Durvalumab Manufacturers Ranked by Revenue (2021)
4.1.2 Global Durvalumab Revenue by Manufacturer (2017-2022)
4.1.3 Global Durvalumab Sales by Manufacturer (2017-2022)
4.1.4 Global Durvalumab Price by Manufacturer (2017-2022)
4.2 Global Durvalumab Concentration Ratio (CR)
4.2.1 Durvalumab Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Durvalumab in 2021
4.2.3 Global Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Durvalumab Manufacturing Base Distribution, Product Type
4.3.1 Global Durvalumab Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Durvalumab Product Type
4.3.3 Date of International Manufacturers Enter into Durvalumab Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Durvalumab Market Size by Company
4.5.1 Top Durvalumab Players in United States, Ranked by Revenue (2021)
4.5.2 United States Durvalumab Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Durvalumab Sales by Players (2020, 2021 & 2022)
5 Global Durvalumab Market Size by Region
5.1 Global Durvalumab Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Durvalumab Market Size in Volume by Region (2017-2028)
5.2.1 Global Durvalumab Sales in Volume by Region: 2017-2022
5.2.2 Global Durvalumab Sales in Volume Forecast by Region (2023-2028)
5.3 Global Durvalumab Market Size in Value by Region (2017-2028)
5.3.1 Global Durvalumab Sales in Value by Region: 2017-2022
5.3.2 Global Durvalumab Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Durvalumab Market Size YoY Growth 2017-2028
6.1.2 North America Durvalumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Durvalumab Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Durvalumab Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Durvalumab Market Size YoY Growth 2017-2028
6.3.2 Europe Durvalumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Durvalumab Market Size YoY Growth 2017-2028
6.4.2 Latin America Durvalumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Durvalumab Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Durvalumab Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Medimmune (AstraZeneca)
7.1.1 Medimmune (AstraZeneca) Corporation Information
7.1.2 Medimmune (AstraZeneca) Description and Business Overview
7.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
7.1.5 Medimmune (AstraZeneca) Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Durvalumab Industry Chain Analysis
8.2 Durvalumab Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Durvalumab Distributors
8.3 Durvalumab Production Mode & Process
8.4 Durvalumab Sales and Marketing
8.4.1 Durvalumab Sales Channels
8.4.2 Durvalumab Distributors
8.5 Durvalumab Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Durvalumab CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Durvalumab Market Trends
Table 3. Durvalumab Market Drivers
Table 4. Durvalumab Market Challenges
Table 5. Durvalumab Market Restraints
Table 6. Global Durvalumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Durvalumab Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Durvalumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Durvalumab Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Durvalumab Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Durvalumab Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Durvalumab Revenue Share by Manufacturer, 2017-2022
Table 13. Global Durvalumab Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Durvalumab Sales Share by Manufacturer, 2017-2022
Table 15. Global Durvalumab Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Durvalumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Durvalumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Durvalumab as of 2021)
Table 18. Top Players of Durvalumab in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Durvalumab Product Type
Table 20. Date of International Manufacturers Enter into Durvalumab Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Durvalumab Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Durvalumab Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Durvalumab Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Durvalumab Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Durvalumab Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Durvalumab Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Durvalumab Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Durvalumab Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Durvalumab Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Durvalumab Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Durvalumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Durvalumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Durvalumab Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Durvalumab Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Durvalumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Durvalumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Durvalumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Durvalumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Durvalumab Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Durvalumab Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Medimmune (AstraZeneca) Corporation Information
Table 43. Medimmune (AstraZeneca) Description and Business Overview
Table 44. Medimmune (AstraZeneca) Durvalumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Medimmune (AstraZeneca) Durvalumab Product
Table 46. Medimmune (AstraZeneca) Recent Development
Table 47. Key Raw Materials Lists
Table 48. Raw Materials Key Suppliers Lists
Table 49. Durvalumab Customers List
Table 50. Durvalumab Distributors List
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Durvalumab Product Picture
Figure 2. Global Durvalumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Durvalumab Market Size 2017-2028 (US$ Million)
Figure 4. Global Durvalumab Sales 2017-2028 (K Pcs)
Figure 5. United States Durvalumab Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Durvalumab Market Size 2017-2028 (US$ Million)
Figure 7. United States Durvalumab Sales 2017-2028 (K Pcs)
Figure 8. United States Durvalumab Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Durvalumab Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Durvalumab Report Years Considered
Figure 11. Product Picture of 2.4mL Injection
Figure 12. Product Picture of 10mL Injection
Figure 13. Global Durvalumab Market Share by Type in 2022 & 2028
Figure 14. Global Durvalumab Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Durvalumab Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Durvalumab Sales by Type (2017-2028) & (K Pcs)
Figure 17. Global Durvalumab Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Durvalumab Price by Type (2017-2028) & (USD/Pcs)
Figure 19. United States Durvalumab Market Share by Type in 2022 & 2028
Figure 20. United States Durvalumab Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Durvalumab Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Durvalumab Sales by Type (2017-2028) & (K Pcs)
Figure 23. United States Durvalumab Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Durvalumab Price by Type (2017-2028) & (USD/Pcs)
Figure 25. Product Picture of Locally Advanced Urothelial Carcinoma
Figure 26. Product Picture of Metastatic Urothelial Carcinoma
Figure 27. Product Picture of Other
Figure 28. Global Durvalumab Market Share by Application in 2022 & 2028
Figure 29. Global Durvalumab Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Durvalumab Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Durvalumab Sales by Application (2017-2028) & (K Pcs)
Figure 32. Global Durvalumab Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Durvalumab Price by Application (2017-2028) & (USD/Pcs)
Figure 34. United States Durvalumab Market Share by Application in 2022 & 2028
Figure 35. United States Durvalumab Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Durvalumab Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Durvalumab Sales by Application (2017-2028) & (K Pcs)
Figure 38. United States Durvalumab Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Durvalumab Price by Application (2017-2028) & (USD/Pcs)
Figure 40. North America Durvalumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 41. North America Durvalumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Durvalumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 45. Europe Durvalumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Durvalumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 52. Asia-Pacific Durvalumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Durvalumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 64. Latin America Durvalumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Middle East & Africa Durvalumab Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 69. Middle East & Africa Durvalumab Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Turkey Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Saudi Arabia Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. U.A.E Durvalumab Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Durvalumab Value Chain
Figure 74. Durvalumab Production Process
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Medimmune (AstraZeneca)